相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Resveratrol accelerates wound healing by attenuating oxidative stress-induced impairment of cell proliferation and migration
Xueqing Zhou et al.
BURNS (2021)
Epidemiology of Multidrug-Resistant Pseudomonas aeruginosa in the Middle East and North Africa Region
Mahmood Al-Orphaly et al.
MSPHERE (2021)
Synergistic Activity of Colistin Combined With Auranofin Against Colistin-Resistant Gram-Negative Bacteria
Xiaoxuan Feng et al.
FRONTIERS IN MICROBIOLOGY (2021)
Polymyxin Resistance in Klebsiella pneumoniae: Complexity at Every Level
Yohei Doi et al.
CLINICAL INFECTIOUS DISEASES (2020)
Efficacy of Topical Antimicrobial Agents Against Bacterial Isolates From Burn Wounds
William Nethery et al.
JOURNAL OF BURN CARE & RESEARCH (2020)
Polymyxin B resistance rates in carbapenem-resistant Pseudomonas aeruginosa isolates and a comparison between Etest(R) and broth microdilution methods of antimicrobial susceptibility testing
Xu Chen et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2020)
Resveratrol enhances the antimicrobial effect of polymyxin B on Klebsiella pneumoniae and Escherichia coli isolates with polymyxin B resistance
Li Liu et al.
BMC MICROBIOLOGY (2020)
Pseudomonas aeruginosa Biofilms
Minh Tam Tran Thi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Rescued chlorhexidine activity by resveratrol against carbapenem-resistant Acinetobacter baumannii via down-regulation of AdeB efflux pump
Uthaibhorn Singkham-In et al.
PLOS ONE (2020)
International Consensus Guidelines for the Optimal Use of the Polymyxins Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP)
Brian T. Tsuji et al.
PHARMACOTHERAPY (2019)
Anticancer effects of resveratrol in canine hemangiosarcoma cell lines
A. Carlson et al.
VETERINARY AND COMPARATIVE ONCOLOGY (2018)
Meloxicam inhibits biofilm formation and enhances antimicrobial agents efficacy by Pseudomonas aeruginosa
Pengfei She et al.
MICROBIOLOGYOPEN (2018)
Metabolism and pharmacokinetics of resveratrol and pterostilbene
Pei Wang et al.
BIOFACTORS (2018)
Resveratrol enhances the efficacy of aminoglycosides against Staphylococcus aureus
Katrine Nohr-Meldgaard et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2018)
Association between biofilm and multi/extensive drug resistance in diabetic foot infection
Asli Vatan et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2018)
Increased antibiotic resistance exhibited by the biofilm of Vibrio cholerae O139
Preeti Gupta et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
Epidemiology, Biology, and Impact of Clonal Pseudomonas aeruginosa Infections in Cystic Fibrosis
Michael D. Parkins et al.
CLINICAL MICROBIOLOGY REVIEWS (2018)
An outbreak of multidrug-resistant Pseudomonas aeruginosa in a burns service in the North of England: challenges of infection prevention and control in a complex setting
V Decraene et al.
JOURNAL OF HOSPITAL INFECTION (2018)
Synergistic Activity of Colistin in Combination With Resveratrol Against Colistin-Resistant Gram-Negative Pathogens
Antonio Cannatelli et al.
FRONTIERS IN MICROBIOLOGY (2018)
Nephrotoxicity of Polymyxins: Is There Any Difference between Colistimethate and Polymyxin B?
Alexandre P. Zavascki et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Pseudomonas aeruginosa prevalence, antibiotic resistance and antimicrobial use in Chinese burn wards from 2007 to 2014
Yi Dou et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2017)
Polymyxins: Antibacterial Activity, Susceptibility Testing, and Resistance Mechanisms Encoded by Plasmids or Chromosomes
Laurent Poirel et al.
CLINICAL MICROBIOLOGY REVIEWS (2017)
Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study
Yi-Yun Liu et al.
LANCET INFECTIOUS DISEASES (2016)
Pseudomonas aeruginosa biofilm: Potential therapeutic targets
Garima Sharma et al.
BIOLOGICALS (2014)
When Does 2 Plus 2 Equal 5? A Review of Antimicrobial Synergy Testing
Christopher D. Doern
JOURNAL OF CLINICAL MICROBIOLOGY (2014)
Multidrug-Resistant Gram-Negative Bacterial Infections: Are you Ready for the Challenge?
Daniel Curcio
CURRENT CLINICAL PHARMACOLOGY (2014)
Resveratrol plus carboxymethyl-β-glucan in children with recurrent respiratory infections: a preliminary and real-life experience
Alfonso Maria Varricchio et al.
ITALIAN JOURNAL OF PEDIATRICS (2014)
Characterization of the Polymyxin B Resistome of Pseudomonas aeruginosa
Luca Fernandez et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Colistin: an update on the antibiotic of the 21st century
Silpak Biswas et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2012)
Resistance to polymyxins: Mechanisms, frequency and treatment options
Matthew E. Falagas et al.
DRUG RESISTANCE UPDATES (2010)
Why chronic wounds will not heal: a novel hypothesis
Thomas Bjarnsholt et al.
WOUND REPAIR AND REGENERATION (2008)
Biofilms in chronic wounds
Garth A. James et al.
WOUND REPAIR AND REGENERATION (2008)
Topical triple-anti biotic ointment as a novel therapeutic choice in wound management and infection prevention: a practical perspective
Robert A. Bonomo et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2007)
Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent
David J. Boocock et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
Contribution of the PhoP-PhoQ and PmrA-PmrB two-component regulatory systems to Mg2+-induced gene regulation in Pseudomonas aeruginosa
Joseph B. McPhee et al.
JOURNAL OF BACTERIOLOGY (2006)
Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections
Jian Li et al.
LANCET INFECTIOUS DISEASES (2006)
Colistin: The revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections
ME Falagas et al.
CLINICAL INFECTIOUS DISEASES (2005)
National surveillance of antimicrobial resistance in Pseudomonas aeruginosa isolates obtained from intensive care unit patients from 1993 to 2002
MD Obritsch et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004
D Cardo et al.
AMERICAN JOURNAL OF INFECTION CONTROL (2004)
The efficacy and safety of topical polymyxin B, neomycin and gramicidin for treatment of presumed bacterial corneal ulceration
MI Bosscha et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2004)
Riddle of biofilm resistance
K Lewis
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Role of antibiotic penetration limitation in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin
JN Anderl et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
分享论文
